Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effect of SDZ RAD on transplant arteriosclerosis in the rat aortic model.

× No keyword cloud information.

10 in total

Review 1. Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part II.

Authors: Caroline Monchaud; Pierre Marquet
Journal: Clin Pharmacokinet Date: 2009 Impact factor: 6.447

Review 2. Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part I.

Authors: Caroline Monchaud; Pierre Marquet
Journal: Clin Pharmacokinet Date: 2009 Impact factor: 6.447

Review 3. mTOR inhibitors in pediatric kidney transplantation.

Authors: Lars Pape; Thurid Ahlenstiel
Journal: Pediatr Nephrol Date: 2013-06-07 Impact factor: 3.714

Review 4. Everolimus: a review of its use in renal and cardiac transplantation.

Authors: Christopher Dunn; Katherine F Croom
Journal: Drugs Date: 2006 Impact factor: 9.546

Review 5. Use of sirolimus in solid organ transplantation.

Authors: Joshua J Augustine; Kenneth A Bodziak; Donald E Hricik
Journal: Drugs Date: 2007 Impact factor: 9.546

6. Safety and tolerability of the T-cell depletion protocol coupled with anakinra and etanercept for clinical islet cell transplantation.

Authors: Morihito Takita; Shinichi Matsumoto; Masayuki Shimoda; Daisuke Chujo; Takeshi Itoh; Jeffrey A Sorelle; Kerri Purcell; Nicholas Onaca; Bashoo Naziruddin; Marlon F Levy
Journal: Clin Transplant Date: 2012 Sep-Oct Impact factor: 2.863

7. Everolimus.

Authors: Therese M Chapman; Caroline M Perry
Journal: Drugs Date: 2004 Impact factor: 9.546

8. The novel immunosuppressant SDZ-RAD protects rat brain slices from cyclosporine-induced reduction of high-energy phosphates.

Authors: N Serkova; L Litt; D Leibfritz; B Hausen; R E Morris; T L James; L Z Benet; U Christians
Journal: Br J Pharmacol Date: 2000-02 Impact factor: 8.739

9. Physiologically based pharmacokinetic (PBPK) modeling of everolimus (RAD001) in rats involving non-linear tissue uptake.

Authors: Robert Laplanche; Guy M L Meno-Tetang; Ryosei Kawai
Journal: J Pharmacokinet Pharmacodyn Date: 2007-03-13 Impact factor: 2.410

10. A 3-month, Multicenter, Randomized, Open-label Study to Evaluate the Impact on Wound Healing of the Early (vs Delayed) Introduction of Everolimus in De Novo Kidney Transplant Recipients, With a Follow-up Evaluation at 12 Months After Transplant (NEVERWOUND Study).

Authors: Tommaso Maria Manzia; Mario Carmellini; Paola Todeschini; Antonio Secchi; Silvio Sandrini; Enrico Minetti; Lucrezia Furian; Gionata Spagnoletti; Francesco Pisani; Gian Benedetto Piredda; Gianni Cappelli; GIuseppe Tisone
Journal: Transplantation Date: 2020-02 Impact factor: 5.385

10 in total